Product Information
EMEND 125 MG POWDER PACKET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $327.3840 per EA under NDC 00006306603. Its NADAC has been published 110 times since Jul 17, 2024.
FDA first approved this application on Dec 17, 2015.
The High Outlier badge above means this manufacturer's average price in the aprepitant market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
125 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006306603
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
APREPITANTApproval Type
New Drug (NDA)
FDA Application
NDA207865FDA Approved
12/17/2015
On Market Since
12/17/2015
Pharmacological Classes
Price Statistics
The NADAC for EMEND 125 MG POWDER PACKET has been published 110 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $327.3840 per EA |
|---|---|
| All-time high | $327.8980 (Aug 12, 2026) |
| All-time low | $324.0400 (Jul 23, 2025) |
| 52-week high | $327.8980 |
| 52-week low | $325.1171 |
| Median price | $325.3075 |
| Average price | $325.6771 |
| Largest weekly change | +0.6% (May 20, 2026) |
| Weeks tracked | 110 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the aprepitant market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EMEND 125 MG POWDER PACKET?
The current National Average Drug Acquisition Cost (NADAC) for EMEND 125 MG POWDER PACKET, manufactured by Merck Sharp & Dohme LLC, is $327.3840 per EA (NDC 00006306603), effective Aug 19, 2026.
How has the price of EMEND 125 MG POWDER PACKET changed over time?
Over the history we have for it, the NADAC for EMEND 125 MG POWDER PACKET has held within roughly two percent of its current level. It has been tracked across 110 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for EMEND 125 MG POWDER PACKET?
Since Jul 17, 2024, the NADAC for EMEND 125 MG POWDER PACKET has ranged from a low of $324.0400 (Jul 23, 2025) to a high of $327.8980 (Aug 12, 2026), with a median of $325.3075 per EA.
Are there cheaper alternatives to EMEND 125 MG POWDER PACKET?
No other NADAC-published product currently shares the active ingredient and strength of EMEND 125 MG POWDER PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EMEND 125 MG POWDER PACKET?
EMEND 125 MG POWDER PACKET (NDC 00006306603) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.